Comparison of add-on treatment with Aliskiren versus Diuretics to angiotensin II receptor blocker based Therapy
Not Applicable
- Conditions
- Essential hypertension
- Registration Number
- JPRN-UMIN000005726
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesDepartment of Cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
1, Secondary hypertension 2, Severe hypertension(SBP 200mmHg or more or DBP 115mmHg or more) 3, Congestive heart failure 4, Severe valvular disease 5, Myocardial infarction or acute period of cerebrovascular disease(within 6 months) 6, Atrial fibrillation(paroxysmal,stained,chronic) 7, Malignant ventricular arrhythmia 8, Renal insufficiency(Serum creatinine 2mg/dL or more) 9, Severe Liver Dysfunction 10, Chronic inflammatory disease 11, The patient with a malignant tumor 12, Patients who are determined by the investigators to be unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in AI, Center blood pressure, SBP2 after 24 weeks
- Secondary Outcome Measures
Name Time Method